Revista espanola de cardiologia · 2007
[Influence of cardiopathy etiology on responses to cardiac resynchronization therapy].
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vidal Bàrbara, Sitges Marta, Delgado Victoria, Mont Lluís, Díaz-Infante Ernesto, Azqueta Manel, Paré Carles, Tolosana José M, Berruezo Antonio, Tamborero David, Roig Eulàlia, Brugada Josep
Аннотация
INTRODUCTION AND OBJECTIVES: Little is known about how responses to cardiac resynchronization therapy (CRT) are affected by the nature of the underlying cardiopathy. The aim of this study was to investigate how cardiopathy etiology influences the effect of CRT on reverse left ventricular remodeling.
METHODS: The study included 106 patients with left ventricular systolic dysfunction and left bundle branch block (LBBB) who were receiving CRT. Clinical and echocardiographic investigations were performed at baseline before implantation and at 6 and 12 month follow-up to determine left ventricular diameter, volume and systolic function, and to quantify mitral regurgitation.
RESULTS: During follow-up, it was observed that CRT reduced left ventricular volume and diameter, increased left ventricular ejection fraction (LVEF), and reduced mitral regurgitation severity irrespective of the etiology of the cardiopathy. In patients with ischemic dilated cardiomyopathy, LVEF increased by 34% and end-diastolic and end-systolic volumes decreased by 4% and 12%, respectively; in those with idiopathic dilated cardiomyopathy, LVEF increased by 38% and end-diastolic and end-systolic volumes decreased by 13% and 19%, respectively (P=NS for ischemic vs. non-ischemic disease). Nor were differences observed between the groups in clinical outcome: 74% of the ischemic group responded compared with 62% of the non-ischemic group (P=NS).
CONCLUSIONS: At 12-month follow-up, patients with left ventricular systolic dysfunction and LBBB treated by CRT showed clinical improvements and demonstrated reverse ventricular remodeling, irrespective of the etiology of their cardiopathy.
METHODS: The study included 106 patients with left ventricular systolic dysfunction and left bundle branch block (LBBB) who were receiving CRT. Clinical and echocardiographic investigations were performed at baseline before implantation and at 6 and 12 month follow-up to determine left ventricular diameter, volume and systolic function, and to quantify mitral regurgitation.
RESULTS: During follow-up, it was observed that CRT reduced left ventricular volume and diameter, increased left ventricular ejection fraction (LVEF), and reduced mitral regurgitation severity irrespective of the etiology of the cardiopathy. In patients with ischemic dilated cardiomyopathy, LVEF increased by 34% and end-diastolic and end-systolic volumes decreased by 4% and 12%, respectively; in those with idiopathic dilated cardiomyopathy, LVEF increased by 38% and end-diastolic and end-systolic volumes decreased by 13% and 19%, respectively (P=NS for ischemic vs. non-ischemic disease). Nor were differences observed between the groups in clinical outcome: 74% of the ischemic group responded compared with 62% of the non-ischemic group (P=NS).
CONCLUSIONS: At 12-month follow-up, patients with left ventricular systolic dysfunction and LBBB treated by CRT showed clinical improvements and demonstrated reverse ventricular remodeling, irrespective of the etiology of their cardiopathy.